ARTICLE SUMMARY:
A conversation with inventor, innovator, and entrepreneur Paul Yock, who, throughout his long career, embraced new approaches to everything he tackled. Value, structure, and ownership of healthcare data raises dealmaking challenges; strategies of the four major players in electrophysiology; start-ups make breast cancer intervention more precise and patient-centered; Medtronic capitalizes on NCD for renal denervation; and Italy's Angelini Ventures ups its commitment to neurotech CoMind.
